Eevia Health Plc receives a 230 KSEK/21 KEUR starting sales order for a new Lingonberry product to a new customer
Eevia Health Plc, (”Eevia” or ”The Company”), has received a 21 KEUR sales order from its Australian distributor Ingredients Plus for a new product made from Lingonberry, after a new customer has decided to launch a new product with the Lingonberry ingredient as a key component.The end customer, which is new to Eevia, is a major natural health company based out of Sydney, Australia selling its consumer products across Oceania. The sales value to Eevia of this new order is c. 21 000 EUR. The product is a Lingonberry extract that contains bioactive proanthocyanidins, a bioactive compound